Literature DB >> 31424714

Resolution of Guttate Psoriasis Plaques After One-time Administration of Guselkumab

Shalanda L. Hall, Wasim Haidari, Steven R. Feldman.   

Abstract

Guttate psoriasis is an acute subtype of plaque psoriasis characterized by eruption of small, scaly plaques, and papules, 5 to 10 mm in size over the trunk and proximal extremities.1 It often arises in children and young adults concomitantly with or shortly after a streptococcal throat infection or tonsillitis. Patients with chronic plaque psoriasis can also experience guttate flares following streptococcal throat infections.1,2 Controlling guttate psoriasis with topical corticosteroids is difficult to achieve due to numerous widespread lesions. Other treatment options include phototherapy and short term use of cyclosporine or methotrexate, as guttate variants of psoriasis can remit with these treatments.1,2 Guselkumab, an inhibitor of the p19 cytokine subunit of interleukin-23 and interleukin-39, produces dramatic resolutions of plaque psoriasis with long lasting effects.3 This case report describes a patient with a guttate variant of plaque psoriasis that resolved after a single administration of guselkumab and continues to remain clear more than 6 months after treatment with guselkumab.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31424714

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  2 in total

1.  Risankizumab for Plaque and Guttate Psoriasis in a Patient with IgA-Related Glomerulonephritis.

Authors:  Annunziata Dattola; Arianna Zangrilli; Luca Bianchi
Journal:  Dermatol Pract Concept       Date:  2021-10-01

2.  A case series of early biologic therapy in guttate psoriasis: Targeting resident memory T cell activity as a potential novel therapeutic modality.

Authors:  Akshay Flora; John W Frew
Journal:  JAAD Case Rep       Date:  2022-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.